CHARLES G. MOERTEL LECTURER

The Moertel Lecture Endowment Fund was established in 1995 to honor the legacy of Charles G. Moertel, MD, as the founder of the North Central Cancer Treatment Group (NCCTG), one of the three legacy groups that formed the Alliance for Clinical Trials in Oncology. Dr. Moertel was known for his dedication to high-quality clinical research that provided practice-changing evidence to benefit patient care in the community setting.

The Moertel Lecturer is an investigator whose research within the National Clinical Trials Network and the NCI Community Oncology Research Program has resulted in a major impact on community cancer practice. Any member of the Alliance may nominate such a lecturer. The award is presented each year during the Plenary Session of the Alliance Spring Group Meeting. The selection committee consists of the Co-Chairs of the Alliance Community Oncology Committee and the Alliance Principal Investigator at the Mayo Clinic.

The recipient for the 2024 Moertel Lecture award is Monica M. Bertagnolli, MD, former Director of the National Institutes of Health.

For more information about this award, please e-mail Niveditha Subbiah, Alliance CCP Program Manager, at niveditha@alliancenctn.org.